Sagimet Biosciences Inc. Series A Common Stock — Institutional Ownership
Which tracked institutions hold SGMT, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
11
Funds holding
$8729023
Total value held
Buying
9 added/new · 1 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $4179702 | 799943 | -14010 | -1.72% |
| 2 | Raymond James Financial Inc | $1659199 | 317550 | +31300 | +10.93% |
| 3 | Goldman Sachs Group Inc | $884379 | 169259 | +43313 | +34.39% |
| 4 | State Street Corp | $672917 | 128788 | +11400 | +9.71% |
| 5 | Morgan Stanley | $487529 | 93307 | +4063 | +4.55% |
| 6 | Northern Trust Corp | $290045 | 55511 | — | Held |
| 7 | Bank Of America Corp /De/ | $229158 | 43858 | +33982 | +344.09% |
| 8 | Barclays Plc | $143316 | 27429 | — | NEW BUY |
| 9 | Citigroup Inc | $106418 | 17976 | — | NEW BUY |
| 10 | Wells Fargo & Company/Mn | $47360 | 8000 | +1000 | +14.29% |
| 11 | Royal Bank Of Canada | $29000 | 5576 | — | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.